Speciality Medicines share price
BSE: 544738Pharmaceuticals & BiotechnologySmall Cap
Last close ₹141.80down ₹7.20 (4.83%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹149.00.
Range of traded prices from listing on 30 Mar 2026 to 8 Oct 2026
₹121.10Low, 6 Apr 2026₹381.20High, 29 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹125 Cr2,392nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 May 2026
- 9.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Mar 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 28 May 2026
- 18.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 16,000
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 28 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹45 Crup 46.82%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹8.18 Crup 68.71%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 18.3%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2025Filed 28 May | Mar 2026Filed 28 May |
|---|---|---|
| Revenue | 30.5 | 44.8 |
| Net profit | 4.9 | 8.2 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 15.9% | 18.3% |
Standalone. The 2 half years from Sep 2025, the first on record. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Marketing and Distribution finished pharmaceutical formulations, which carries all its revenue.
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Speciality Medicines in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Bal PharmaBALPHARMA | 129 | 17.9 | 1.6 | 8.4 | +13.5% | +1.3% | 9.0% | 9.3% | 1.48% |
 Panchsheel OrganicPANCHSHEEL | 128 | 12.4 | 0.9 | 9.9 | +2.3% | – | 7.5% | 7.3% | 3.30% |
 Par Drugs and ChemicalsPAR | 127 | 8.8 | 1.1 | 4.3 | +4.3% | +2.4% | 13.7% | 14.5% | 0.00% |
 Lactose (India)LACTOSE | 125 | 18.1 | 1.9 | 9.6 | +34.9% | +57.8% | 11.2% | 10.6% | 0.00% |
 Godavari DrugsGODAVARI | 122 | 29.3 | 1.6 | 18.5 | +4.8% | +9.7% | 7.0% | 4.9% | 0.00% |
| Himalaya Nutravedics IndiaHNIL | 121 | – | – | – | – | – | – | – | 0.00% |
 Parnax LabPARNAXLAB | 119 | 13.3 | 1.2 | 7.9 | +31.9% | −17.3% | 10.0% | 9.3% | 0.00% |
 BALAXI PHARMACEUTICALSBALAXI | 115 | 47.6 | 0.5 | 17.3 | −5.9% | −87.2% | 1.0% | 2.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
12 Aug · Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Approval For Two New Products In Ethiopia
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 155.00 | 155.00 | 140.00 | 141.80 | 144.70 | 16,000 |
| 22 Oct 2026 | 152.25 | 154.85 | 147.00 | 149.00 | 150.19 | 19,000 |
| 21 Oct 2026 | 155.05 | 168.00 | 155.05 | 156.95 | 161.14 | 17,000 |
| 19 Oct 2026 | 156.00 | 170.00 | 156.00 | 167.05 | 166.03 | 8,000 |
| 15 Oct 2026 | 161.50 | 169.95 | 157.00 | 169.95 | 162.78 | 7,000 |
| 14 Oct 2026 | 156.05 | 162.00 | 156.05 | 162.00 | 160.35 | 6,000 |
| 13 Oct 2026 | 164.00 | 167.95 | 160.00 | 160.05 | 163.10 | 10,000 |
| 12 Oct 2026 | 169.00 | 173.00 | 166.10 | 168.05 | 169.18 | 12,000 |
| 9 Oct 2026 | 190.70 | 190.70 | 165.05 | 168.50 | 173.34 | 49,000 |
| 8 Oct 2026 | 210.00 | 210.00 | 189.95 | 190.70 | 197.70 | 40,000 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- SPECIALITY MEDICINES LIMITED
- BSE code
- 544738
- ISIN
- INE0R0M01014
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Mar 2026
- Face value
- ₹10
- CIN
- U85300GJ2021PLC120022
- Corporate identity number, the registrar of companies' code for it
In BSE SME IPO